Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
NPJ Parkinson'S Disease
|
October 11, 2018
'Levodopa Phobia': a review of a not uncommon and consequential phenomenon
Nataliya Titova, Oleg Levin, Elena Katunina, et al.
International Review of Neurobiology
|
April 10, 2022
The pathophysiology of sexual dysfunction in Parkinson's disease: An overview
Lucia Batzu, Nataliya Titova, Kalyan B Bhattacharyya, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
August 5, 2020
Therapy of Parkinson's Disease Subtypes
Connie Marras, K Ray Chaudhuri, Nataliya Titova, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
November 9, 2017
Advanced Parkinson's or "complex phase" Parkinson's disease? Re-evaluation is needed
Nataliya Titova, Pablo Martinez-Martin, Elena Katunina, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
December 29, 2016
Parkinson's: a syndrome rather than a disease?
Nataliya Titova, C Padmakumar, Simon J G Lewis, et al.
Journal of Personalized Medicine
|
December 24, 2021
Genetic Markers as Risk Factors for the Development of Impulsive-Compulsive Behaviors in Patients with Parkinson's Disease Receiving Dopaminergic Therapy
Anna Fedosova, Nataliya Titova, Zarema Kokaeva, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
|
February 27, 2020
Alzheimer's Disease and Parkinson Dementia Distinguished by Cognitive Marker
Irina Kozlova, Mario A Parra, Nataliya Titova, et al.
Journal of Personalized Medicine
|
December 23, 2022
The Dashboard Vitals of Parkinson's: Not to Be Missed Yet an Unmet Need
Kallol Ray Chaudhuri, Nataliya Titova, Mubasher A Qamar, et al.
International Review of Neurobiology
|
May 31, 2017
Palliative Care for Patients and Families With Parkinson's Disease
Raquel Bouça-Machado, Nataliya Titova, K Ray Chaudhuri, et al.
Expert Review of Neurotherapeutics
|
August 7, 2020
'Dopamine agonist Phobia' in Parkinson's disease: when does it matter? Implications for non-motor symptoms and personalized medicine
Silvia Rota, Iro Boura, Lucia Batzu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
NPJ Parkinson'S Disease
|
October 11, 2018
'Levodopa Phobia': a review of a not uncommon and consequential phenomenon
Nataliya Titova, Oleg Levin, Elena Katunina, et al.
International Review of Neurobiology
|
April 10, 2022
The pathophysiology of sexual dysfunction in Parkinson's disease: An overview
Lucia Batzu, Nataliya Titova, Kalyan B Bhattacharyya, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
August 5, 2020
Therapy of Parkinson's Disease Subtypes
Connie Marras, K Ray Chaudhuri, Nataliya Titova, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
November 9, 2017
Advanced Parkinson's or "complex phase" Parkinson's disease? Re-evaluation is needed
Nataliya Titova, Pablo Martinez-Martin, Elena Katunina, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
December 29, 2016
Parkinson's: a syndrome rather than a disease?
Nataliya Titova, C Padmakumar, Simon J G Lewis, et al.
Journal of Personalized Medicine
|
December 24, 2021
Genetic Markers as Risk Factors for the Development of Impulsive-Compulsive Behaviors in Patients with Parkinson's Disease Receiving Dopaminergic Therapy
Anna Fedosova, Nataliya Titova, Zarema Kokaeva, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
|
February 27, 2020
Alzheimer's Disease and Parkinson Dementia Distinguished by Cognitive Marker
Irina Kozlova, Mario A Parra, Nataliya Titova, et al.
Journal of Personalized Medicine
|
December 23, 2022
The Dashboard Vitals of Parkinson's: Not to Be Missed Yet an Unmet Need
Kallol Ray Chaudhuri, Nataliya Titova, Mubasher A Qamar, et al.
International Review of Neurobiology
|
May 31, 2017
Palliative Care for Patients and Families With Parkinson's Disease
Raquel Bouça-Machado, Nataliya Titova, K Ray Chaudhuri, et al.
Expert Review of Neurotherapeutics
|
August 7, 2020
'Dopamine agonist Phobia' in Parkinson's disease: when does it matter? Implications for non-motor symptoms and personalized medicine
Silvia Rota, Iro Boura, Lucia Batzu, et al.
Page
of 3